Found: 5
Select item for more details and to access through your institution.
A systematic scorecard-based approach to site assessment in preparation for Lassa fever vaccine clinical trials in affected countries.
- Published in:
- Pilot & Feasibility Studies, 2020, v. 6, n. 1, p. 1, doi. 10.1186/s40814-020-00567-4
- By:
- Publication type:
- Article
A Randomized Controlled Phase Ib Trial of the Malaria Vaccine Candidate GMZ2 in African Children.
- Published in:
- PLoS ONE, 2011, v. 6, n. 7, p. 1, doi. 10.1371/journal.pone.0022525
- By:
- Publication type:
- Article
The promise, problems, and pitfalls of including pregnant women in clinical trials of Lassa fever vaccine: a qualitative assessment of sub-Sahara Africa investigators' perception.
- Published in:
- Pan African Medical Journal, 2022, v. 41, p. 1, doi. 242).10.11604/pamj.2022.41.242.33863
- By:
- Publication type:
- Article
Correction: Phase I Clinical Trial of a Recombinant Blood Stage Vaccine Candidate for Plasmodium falciparum Malaria Based on MSP1 and EBA175.
- Published in:
- PLoS ONE, 2015, v. 10, n. 9, p. 1, doi. 10.1371/journal.pone.0137816
- By:
- Publication type:
- Article
Phase I Clinical Trial of a Recombinant Blood Stage Vaccine Candidate for Plasmodium falciparum Malaria Based on MSP1 and EBA175.
- Published in:
- PLoS ONE, 2015, v. 10, n. 4, p. 1, doi. 10.1371/journal.pone.0117820
- By:
- Publication type:
- Article